학술논문

Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy
Document Type
Article
Source
In: Frontiers in Pharmacology. (Frontiers in Pharmacology, 2024, 15)
Subject
Language
English
ISSN
16639812